[ad_1] I donât allocate a lot of capital to penny stocks. Because they tend to be risky investments. However, occasionally I spot an opportunity thatâs really tempting. And MTI Wireless Edge (LSE: MWE) is one of those opportunities. Winning defence…
[ad_1] RH shares tumbled 5.9% on Tuesday to $111.66 after a sweeping wave of analyst downgrades slashed price targets by an average of 21.4% across seven major Wall Street firms. The luxury home furnishings retailer faced one of its worst…
[ad_1] Anyone buying Barclays (LSE: BARC) shares at the beginning of 2024 must be patting themselves on the back now. The share price has more than doubled in value since, while paying out plenty of chunky dividends. An investor who…
[ad_1] Academy Sports and Outdoors (NASDAQ: ASO) shares tumbled 6.0% on Tuesday to trade at $55.52, caught in a broader selloff that dragged down specialty retail peers across the board. The sporting goods retailer saw 434,051 shares change hands as…
[ad_1] S&P 500 software stocks have been hammered recently. It seems investors are worried that new AI tools from the likes of Anthropic and OpenAI are going to crush a lot of businesses. Whatâs interesting is that late last month,…
[ad_1] In a market where most restaurant chains are struggling to balance growth with profitability, CAVA Group is attempting something tricky, scale fast without breaking the business. At first glance, CAVA looks like a classic growth story. A fast-casual brand…
[ad_1] The AstraZeneca (LSE:AZN) share price is approaching all-time highs. A recent catalyst, sending the shares moving upwards by over 3%, was the report that its experimental lung disease medicine hit its targets in two late-stage clinical trials. This was seen as…
[ad_1] Shares of Lennar Corporation (NYSE: LEN) were down 3% on Tuesday. The stock has dropped 19% in the past three months. The homebuilder continues to face challenges from a difficult housing market which in turn continue to impact its…
[ad_1] Tesco (LSE: TSCO) shares have had a stunning run. The UK’s biggest grocer has been behaving more like a whizzy penny stock than a venerable FTSE 100 blue chip. Whatâs going on? A lot of things have gone right.…
[ad_1] Johnson & Johnson (NYSE: JNJ) ended fiscal 2025 on a high note, reporting higher revenues and strong earnings growth for the fourth quarter. The company’s market position remains solid, supported by its diversified healthcare portfolio and resilient balance sheet.…